Forty Seven's IO Antibody Attracts Two Big Pharma Partners

 
• By Lucie Ellis-Taitt
  
Cancer-cells-pink-color_1200x675
More cancer combinations: Forty Seven to pair lead compound with PD-L1s
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer